US 9085578
Heterocyclic compound
granted A61PA61P1/04A61P17/00
Quick answer
US patent 9085578 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 21 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61P, A61P1/04, A61P17/00, A61P17/06, A61P19/02